CClinicalTrials.gg
CompletedNCT02383914Updated Nov 6, 2020

Clinical Study on Diagnostics and Outcome of Ruptures of the Subscapularis After Arthroscopic Refixation

An observational study in Subscapularis Tendon Rupture, sponsored by University of Rostock. Completed at 1 site in Germany. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2020-11-06.

Sponsored by University of Rostock · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
32
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The purpose of the trial is to optimize the diagnostics of subscapularis tendon tears and as the circumstances require to found a new classification.

The prime objective is a comparison of the conclusive of the clinic check-up, the sonographic and magnetic resonance tomography findings.

The secondary objective is to detect the correlation of the outcome with the age , the gender, the pathogenesis and attendant injuries.

02

Conditions studied

  • Subscapularis Tendon Rupture

Browse trials for

03

In context

Rupture

557 studies on the registry are indexed under Rupture; 97 are open to participants now.

This study's enrollment of 32 is below the median of 100 across 203 observational studies indexed under Rupture.

Browse Rupture studies →

Lead sponsor

University of Rostock is the lead sponsor of 46 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of the patients, who got the operative therapy (refixaton of the subscapularis tendon) inclusive the post- treatment and satisfy the criteria .

Inclusion criteria

  • patients, who have turned 18
  • suspected subscapularis tendon rupture

Exclusion criteria

Exclusion Criteria:

  • disability to understand the trial
  • intraoperative intact supbscapularis tendon
  • pre-surgical operation of the affected shoulder
  • tumor
  • infection
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
32 participants (actual)
Patient registry
No

Groups and cohorts

  • Subscapularis rupture
06

What researchers measure

Primary outcomes

  1. Shoulder function (Constant Score)

    Time frame: 52 weeks post- operative

Secondary outcomes

  1. Strength

    Strength will be measured by a special force sensor

    Time frame: 12 and 52 weeks post-operative

  2. Rerupture Rate

    Sonographic investigation of rerupture rate

    Time frame: 12 and 52 weeks post-operative

07

Study locations

1 site
  • Orthopaedic Clinic of the University of Rostock
    Rostock, Mecklenburg-Vorpommern 18057, Germany
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 6, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02383914
Lead sponsor
University of Rostock
Responsible party
PD Dr. med. Thomas Tischer (Prof. Dr. med. Thomas Tischer, University of Rostock) — Principal investigator
First posted
Mar 10, 2015
Start date
Mar 2014
Primary completion
Dec 2017
Completion
Oct 2018
Last update
Nov 6, 2020
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion